Astoria, NY, United States of America

Fabien Campagne

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Cornell University, The Feinstein Institutes for Medical Research. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabien Campagne. Retrieved from https://idiyas.com/inventor/fabien-campagne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fabien Campagne: Innovator in Organ Transplantation and Alzheimer's Research

Introduction

Fabien Campagne is a notable inventor based in Astoria, NY (US). He has made significant contributions to the fields of organ transplantation and Alzheimer's disease research. With a total of 2 patents, his work focuses on innovative methods that address critical health challenges.

Latest Patents

One of his latest patents is a "Method to match organ donors to recipients for transplantation." This invention describes an allogenomics mismatch scoring method that estimates the genomic incompatibility between potential organ donors and transplant recipients. The allogenomics method addresses immunological concerns and compares genotype information from matched or potential donors and recipients. It utilizes genomic data available before transplantation and predicts kidney graft function for over three years post-transplantation. The strength of the inverse correlation between pre-transplantation genomic mismatches and transplant organ function increases with time after transplantation. A low allogenomics mismatch score correlates with better acceptance and function of a donor transplant over time.

Another significant patent is the "Method of screening compounds using CALHM (FAM26C)." This invention provides methods for screening test compounds to determine their ability to alter calcium homeostasis in mammalian cells. It experimentally assesses whether a compound affects CALHM1, CALHM2, or CALHM3 expression or activity. Additionally, it includes methods for screening compounds that may inhibit ERK 1/2 phosphorylation and amyloid-beta peptide accumulation, which are crucial in Alzheimer's disease research.

Career Highlights

Fabien Campagne has worked with prestigious institutions such as Cornell University and The Feinstein Institute for Medical Research. His work in these organizations has allowed him to contribute to groundbreaking research and innovations in medical science.

Collaborations

He has collaborated with notable colleagues, including Laurent Mesnard and Manikkam Suthanthiran. These partnerships have further enhanced his research capabilities and broadened the impact of his inventions.

Conclusion

Fabien Campagne's innovative work in organ transplantation and Alzheimer's disease research exemplifies the importance of scientific advancements in improving health outcomes. His patents reflect a commitment to addressing significant medical challenges through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…